M. Kaname et al. / Tetrahedron Letters 42 (2001) 2713–2716
2715
4. (a) Yuan, C.; Li, C. Synthesis 1996, 507–510; (b) Lan-
glois, N.; Rousseau, A.-R.; Decavallas, O. Tetrahedron:
Asymmetry 1996, 7, 1095–1100.
5. Kaname, M.; Yoshinaga, K.; Arakawa, Y.; Yoshifuji, S.
Tetrahedron Lett. 1999, 40, 7993–7994.
fortunately, the ring-contracted five-membered lactam
9a in 77% yield. Lactam 9a was smoothly hydrogenated
in 2N HCl using PtO2 at 4 atm of H2 through a one-pot
operation combined with hydrogenolysis of the NꢀN
bond and reduction of the lactam C=O function, and
then treated by ion-exchange chromatography (Dowex
50W) to furnish the desired pyrrolidine-2-phosphonic
6. Brimble, M. A.; Heathcock, C. H.; Nobin, G. N. Tetra-
hedron: Asymmetry 1996, 7, 2007–2016.
acid (−)-10, mp 275–276°C (lit.9 mp 275–276°C) in 73%
7. One-pot reaction (preparation of compound 5):
Trimethyl phosphite (8.85 ml, 75.0 mmol) was added
slowly to a solution of di-(−)-menthyl azodicarboxylate
(11.84 g, 30.0 mmol) and trimethylsilyloxy-1,3-butadiene
(or 1-methoxy-1,3-butadiene) (60.0 mmol) in CH2Cl2 (40
ml) at room temperature. Then, TMSOTf (8.14 ml, 45.0
mmol) was dropped slowly in the reaction mixture at
0°C. The solution was allowed to warm to room temper-
ature and was held there for 12 h. Water (30 ml) was
added dropwise to the reaction solution at 0°C, and the
mixture was vigorously stirred for 30 min. The mixture
was diluted with saturated aq. NaHCO3 (300 ml) and
extracted with AcOEt (twice, total 800 ml). The AcOEt
solution was washed with saturated aq. NaCl, dried over
anhyd. Na2SO4, and concentrated in vacuo. The residue
was purified by silica gel column chromatography
(AcOEt–hexane, 1:1ꢀ2:1 v/v) to give an inseparable mix-
ture of (3R)- and (3S)-di-(−)-menthyl 3-dimethylphos-
phoryl-1,2,3,6-tetrahydropyridazine-1,2-dicarboxylate (5).
Yield 100% (or 73% from 1-methoxy-1,3-butadiene), col-
orless oil. MS m/z: 556 (M+). 1H NMR (CDCl3) l:
0.64–1.18 (24H, m), 1.18–1.57 (4H, m), 1.57–1.83 (4H,
m), 1.87–2.30 (4H, m), 3.73–3.92 (7H, m), 4.28–4.76 (3H,
m), 4.91–5.33 (1H, m), 5.90–6.05 (2H, br).
20
578
yield. The specific rotation of (−)-10 ([h]
−64.2°
(c=1.03, 1N NaOH) was in accord with the reported
value for (S)-pyrrolidine-2-phosphonic acid ([h] −60°
20
578
(c=1, 1N NaOH)).9
In a similar way, piperidazine derivative 6b, a precursor
of (+)-7, was transformed into the pyrrolidine-2-phos-
phonic acid (+)-10, mp 276–277°C (lit.9 mp 272–273°C),
22
578
[h] +66.3° (c=1.0, 1N NaOH), the optical rotation of
which was in good agreement with that of the known
578
(R)-form, [h] +64° (c=1, 1N NaOH).9
20
Thus, the chemical conversion was successfully accom-
plished. The absolute configuration of the levorotatory
piperidazine-3-phosphonic acid (−)-7 and its precursor
6a was assigned to be (S)-configuration, while that of
the dextrorotatory compound (+)-7 and its derivative
6b to be (R)-configuration.
In summary, the first synthesis of (R)- and (S)-piperi-
dazine-3-phosphonic acids and the related compounds10
provides ready access to a new type of optically active
cyclic a-hydrazinophosphonic acids. Furthermore, the
transformation of the piperidazine derivatives into the
pyrrolidine compounds, which was effectuated by RuO4
oxidation, provides a new synthetic route to useful
compounds having a pyrrolidine ring system.
8. Yoshifuji, S.; Tanaka, K.; Kawai, T.; Nitta, Y. Chem.
Pharm. Bull. 1985, 33, 5515–5521.
9. Lejczak, B.; Kafarski, P.; Mastalerz, P. J. Chromatogr.
1985, 324, 455–461.
10. Data for new compounds are as follows:
Compound 6a: Colorless oil. [h]2D7 −71.7° (c=0.93,
1
References
CHCl3). IR (film): 1732, 1712 cm−1. H NMR (CDCl3) l:
0.67–1.14 (24H, m), 1.20–1.58 (5H, m), 1.61–1.74 (4H,
m), 1.74–2.23 (7H, m), 2.94–3.17 (1H, br), 3.74–3.89 (6H,
m), 3.99–4.22 (1H, m), 4.45–4.84 (3H, m). HRMS m/z:
Calcd for C28H51N2O7P: 558.3434. Found: 558.3434.
Compound 6b: Colorless oil. [h]2D4 −39.9° (c=1.23,
1. (a) De Lombaert, S.; Blanchard, L.; Stamford, L. B.;
Tan, J.; Wallace, E. M.; Satoh, Y.; Fitt, J.; Hover, D.;
Simonsbergen, D.; Moliterni, J.; Marcopoulos, N.; Sav-
age, P. J. Med. Chem. 2000, 43, 488–504; (b) Bird, J.; De
Mello, C. R.; Harper, P. G.; Hunter, J. D.; Karran, H.
E.; Markwell, E. R.; Miles-Williams, J. A.; Rahman, S.
S.; Ward, W. R. J. Med. Chem. 1994, 37, 158–169; (c)
Osipov, S. N.; Artyushin, O. I.; Kolomiets, A. F.;
Bruneau, C.; Dixneuf, P. H. Synlett 2000, 1031–1033; (d)
Tada, S.; Hatano, M.; Nakayama, Y.; Volrath, S.;
Guyer, D.; Ward, E.; Ohta, D. Plant Physiol. 1995, 109,
153–159; (e) Kafarski, P.; Lejczak, B. Phosphorus Sulfur
Silicon Relat. Elem. 1991, 63, 193–215.
1
CHCl3). IR (film): 1732, 1705 cm−1. H NMR (CDCl3) l:
0.72–1.17 (24H, m), 1.22–1.60 (5H, m), 1.60–1.75 (4H,
m), 1.75–2.30 (7H, m), 2.81–3.08 (1H, m), 3.76–3.84 (6H,
m), 4.05–4.25 (1H, m), 4.48–4.90 (3H, m). HRMS m/z:
Calcd for C28H51N2O7P: 558.3434. Found 558.3430.
Compound (−)-7: White powder, mp 163–165°C. [h]D25
−16.0° (c=0.70, 2N HCl). IR (KBr): 3433, 3278, 1157,
1
1084 cm−1. H NMR (D2O) l: 1.56–1.85 (2H, m), 1.90–
2.05 (2H, m), 3.03–3.12 (1H, m), 3.16–3.26 (1H, m),
2. Diel, P.; Maier, L. Eur. Pat. Appl. EP 143078, 1985;
Chem. Abstr. 1985, 103, 15544m.
3.30–3.40 (1H, m). 13C NMR (100 Mz, D2O) l: 21.30 (t),
1
23.72 (t), 46.04 (t), 54.88 (ddP, JCP=146.5 Hz). HRMS
3. (a) Alonso, E.; Alonso, E.; Sol´ıs, A.; del Pozo, C. Synlett
2000, 698–700; (b) Kim, K. S.; Hurh, E. Y.; Youn, J. N.;
Park, J. I. J. Org. Chem. 1999, 64, 9272–9274; (c)
Katritzky, A. R.; Cui, X.-L.; Yang, B.; Steel, P. J. J. Org.
Chem. 1999, 64, 1979–1985; (d) Ranu, B. C.; Haja, A.;
Jana, U. Org. Lett. 1999, 1, 1141–1143; (e) Yager, K. M.;
Taylor, C. M.; Smith, III, A. B. J. Am. Chem. Soc. 1994,
116, 9377–9378.
m/z: Calcd for C4H12N2O3P: 167.0586. Found: 167.0586.
Compound (+)-7: White powder, mp 161–163°C. [h]D26
+13.7° (c=0.67, 2N HCl). Other spectral data, identical
with those of (−)-7.
Compound 8a: Colorless oil. [h]2D2 −38.0° (c=0.73,
CHCl3). IR (film): 1790, 1755, 1720 cm−1 1H NMR
.
(CDCl3) l: 0.67–1.28 (24H, m), 1.28–1.62 (4H, br), 1.62–
1.76 (4H, br), 1.84–2.27 (6H, m), 2.44–2.62 (2H, m),